Human Molecular Genetics Advance Access published online on May 25, 2005
Human Molecular Genetics, doi:10.1093/hmg/ddi198
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medical Genetics, University of Siena, Policlinico "Le Scotte", 53100 Siena, Italy
* To whom correspondence should be addressed. Rett syndrome (RTT) is a severe neurodevelopmental disorder almost exclusively affecting females and characterized by a wide spectrum of clinical manifestations. Most patients affected by classic RTT and a smaller percentage of patients with the milder form "preserved speech variant" have either point mutations or deletions/duplications in the MECP2 gene. Recently, mutations in the CDKL5 gene, coding for a putative kinase, have been found in female patients with a phenotype overlapping with that of RTT. Here we report two patients with the early seizure variant of RTT, bearing two novel CDKL5 truncating mutations, strengthening the correlation between CDKL5 and RTT. Considering the similar phenotypes caused by mutations in MECP2 and CDKL5, it has been suggested that the two genes play a role in common pathogenic processes. We show here that CDKL5 is a nuclear protein whose expression in the nervous system overlaps that of MeCP2, during neural maturation and synaptogenesis. Importantly, we demonstrate that MeCP2 and CDKL5 interact both in vivo and in vitro and that CDKL5 is indeed a kinase, which is able to phosphorylate itself and to mediate MeCP2 phosphorylation, suggesting that they belong to the same molecular pathway. Furthermore, this paper contributes to the clarification of the phenotype associated with CDKL5 mutations and indicates that CDKL5 should be analyzed in each patient showing a clinical course similar to RTT but characterized by a lack of an early normal period due to the presence of seizures.
Received February 16, 2005
Revised April 14, 2005
Accepted May 16, 2005
Article
CDKL5 Belongs to the Same Molecular Pathway of MeCP2 and it is Responsible for the Early Seizure Variant of Rett Syndrome
2 Dipartimento di Biologia Strutturale e Funzionale, Università dell'Insubria, 21052 Busto Arsizio (VA), Italy
3 Stem Cell Research Department, San Raffaele Scientific Institute, 20132 Milano, Italy
4 Department of Pediatrics, University of Siena, Policlinico "Le Scotte", 53100 Siena, Italy
5 Child Neuropsychiatry, Azienda Ospedaliera Senese, 53100 Siena, Italy
Nicoletta Landsberger, E-mail: landsben{at}uninsubria.it
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Ricciardi, C. Kilstrup-Nielsen, T. Bienvenu, A. Jacquette, N. Landsberger, and V. Broccoli CDKL5 influences RNA splicing activity by its association to the nuclear speckle molecular machinery Hum. Mol. Genet., December 1, 2009; 18(23): 4590 - 4602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rusconi, L. Salvatoni, L. Giudici, I. Bertani, C. Kilstrup-Nielsen, V. Broccoli, and N. Landsberger CDKL5 Expression Is Modulated during Neuronal Development and Its Subcellular Distribution Is Tightly Regulated by the C-terminal Tail J. Biol. Chem., October 31, 2008; 283(44): 30101 - 30111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bahi-Buisson, J. Nectoux, H. Rosas-Vargas, M. Milh, N. Boddaert, B. Girard, C. Cances, D. Ville, A. Afenjar, M. Rio, et al. Key clinical features to identify girls with CDKL5 mutations Brain, October 1, 2008; 131(10): 2647 - 2661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Elia, M. Falco, R. Ferri, A. Spalletta, M. Bottitta, G. Calabrese, M. Carotenuto, S. A. Musumeci, M. Lo Giudice, and M. Fichera CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy Neurology, September 23, 2008; 71(13): 997 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bertani, L. Rusconi, F. Bolognese, G. Forlani, B. Conca, L. De Monte, G. Badaracco, N. Landsberger, and C. Kilstrup-Nielsen Functional Consequences of Mutations in CDKL5, an X-linked Gene Involved in Infantile Spasms and Mental Retardation J. Biol. Chem., October 20, 2006; 281(42): 32048 - 32056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H L Archer, J Evans, S Edwards, J Colley, R Newbury-Ecob, F O'Callaghan, M Huyton, M O'Regan, J Tolmie, J Sampson, et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients J. Med. Genet., September 1, 2006; 43(9): 729 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Pelka, C. M. Watson, T. Radziewic, M. Hayward, H. Lahooti, J. Christodoulou, and P. P. L. Tam Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice Brain, April 1, 2006; 129(4): 887 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lin, B. Franco, and M. R. Rosner CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders Hum. Mol. Genet., December 15, 2005; 14(24): 3775 - 3786. [Abstract] [Full Text] [PDF]
|
|